Takahisa Yamashita

6PUBLICATIONS
14CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)AutoimmunityMedical biotechnology diagnostics (incl. biosensors)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 29, 2026
Conversion to Pathological Complete Response by Enfortumab Vedotin in Metastatic Sarcomatoid Urothelial Carcinoma With Nectin-4 Expression: A Case Report.

|Jul 15, 2026
Metabolic and Molecular Mechanisms of Gemcitabine Resistance in Urothelial Carcinoma.

|Sep 05, 2025
Immunoglobulin G4-Related Inflammatory Pseudotumor With Cystic Features Mimicking Renal Cancer.

Yuki Tanaka, Takahisa Yamashita, Kazuki Yokota

|Feb 12, 2025
Evaluation of NANOG/HDAC1 Expression in Predicting Outcomes of BCG Therapy in Non-Muscle Invasive Bladder Cancer.

Takahisa Yamashita, Morihiro Higashi, Mami Yamazaki

|Jun 25, 2021
Fluorescent nanoparticle-mediated semiquantitative MYC protein expression analysis in morphologically diffuse large B-cell lymphoma.

Natsuko Takayanagi, Shuji Momose, Jun Kikuchi

|Jun 02, 2018
Retroperitoneal Cystic Nodal Metastasis of Renal Cell Carcinoma.

Takahisa Yamashita, Makoto Morozumi, Morihiro Higashi

Pageof 1

Frequent Collaborators

2 joint publications

Natsuko Takayanagi

2 joint publications

Sachi Kitayama

2 joint publications

Akihiro Yano

2 joint publications

Yohei Okada